Policy changes Backwork has recorded, newest first. The most recent change on record is from October 14, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
83,427 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Genetic Testing for Epilepsy | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Genetic Testing for Duchenne and Becker Muscular Dystrophy | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Genetic Testing for Diagnosis and Management of Mental Health Conditions | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Genetic Testing for Developmental Delay/Intellectual Disability, Autism Spectrum Disorder, and Congenital Anomalies | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Genetic Testing for Cardiac Ion Channelopathies | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Genetic Testing for Alzheimer Disease | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Genetic Testing for Alpha-1 Antitrypsin Deficiency | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Genetic Testing | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Genetic Cancer Susceptibility Panels Using Next Generation Sequencing | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Genetic and Protein Biomarkers for the Diagnosis and Cancer Risk Assessment of Prostate Cancer | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | General Health Panel | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | General Approach to Genetic Testing | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Gene Therapy for Treatment of Sickle Cell Disease | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Gene Therapy for the Treatment of Metachromatic Leukodystrophy | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Gene Therapy for the Treatment of Hemophilia B | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Gene Therapy for Inherited Retinal Dystrophy | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Gene Expression Testing in the Evaluation of Patients with Stable Ischemic Heart Disease | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Gene Expression Profiling, Protein Biomarkers, and Multimodal Artificial Intelligence for Prostate Cancer Management | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Gene Expression Profiling for Uveal Melanoma | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Gene Expression Profiling for Cutaneous Melanoma | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Gene Expression Profile Testing and Circulating Tumor DNA Testing for Predicting Recurrence in Colon Cancer | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Gender Dysphoria Treatment in Adults | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Gastrointestinal (GI) Function/Health Panel | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Gastric Electrical Stimulation | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Gas Permeable Scleral Contact Lens | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Garments | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Gait Analysis | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Functional Neuromuscular Electrical Stimulation | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Functional Magnetic Resonance Imaging of the Brain for Presurgical Mapping or Seizure Focus Localization | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Free Triiodothyronine (T3) and Reverse T3 | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Free Testosterone Testing | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Fractional Carbon Dioxide (CO2) Laser Ablation Treatment of Hypertrophic Scars or Keloids for Functional Improvement | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Foot Care Services | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Focinvez (fosaprepitant) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Focal Treatments for Prostate Cancer | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | First-Trimester Detection of Down Syndrome Using Fetal Ultrasound Markers Combined with Maternal Serum Assessment | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Fetroja (cefiderocol sulfate tosylate) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Fetal Surgery for Prenatally Diagnosed Malformations | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Felbatol (felbamate) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Fecal Microbiota Transplantation | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Fecal Calprotectin Testing | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Fecal Analysis in the Diagnosis of Intestinal Dysbiosis | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Facet Blocks for Treatment of Back Pain | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Facet Arthroplasty | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Fabhalta (iptacopan) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Eyelid Thermal Pulsation for the Treatment of Dry Eye Syndrome | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Extracranial Carotid Artery Stenting | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Extracorporeal Shock Wave Treatment for Plantar Fasciitis and Other Musculoskeletal Conditions | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Extracorporeal Photopheresis | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | External Infusion Pumps | New policy |